London, United Kingdom, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Rapid Nutrition PLC (Euronext Growth: ALRPD, OTCQB: RPNRF), a natural healthcare company focused on sports nutrition, diet management and life sciences products continues to increase its worldwide distribution, with the expansion of its global distribution of its organic health and wellness products SystemLS throughout South Korea with the support of new partner SM Trading, a division of Ilshin World Corporation. This announcement follows on the heels of the company’s recent distribution agreement with Zone Eight forming part of the RKSB Group in Saudi Arabia last month.
With its focus on serving as the leading distributor of imported products to South Korea, Ilshin’s company-owned warehouses enable top-notch logistics and distribution. Established in 2000, Ilshin exclusively represents brands from across the globe.
“We are incredibly pleased with the way our senior management team continues to execute on our global expansion strategy and deliver on key milestones,” said Rapid Nutrition CEO Simon St. Ledger. “Likewise, we appreciate the expertise that Ilshin World Corporation has throughout South Korea and are pleased to welcome this new partner and new global opportunity as South Korea is showing strong interest in the organic health category.”
The South Korean health and wellness market continues to project upward; the country reported sales value of health and wellness products in 2018 at nearly U.S. $8 billion. The global COVID-19 pandemic further sparked interest and sales of organic products in South Korea.
About Rapid Nutrition
Dedicated to the development and distribution of premium, science-based health and wellness brands across the globe, Rapid Nutrition shares a wealth of award-winning products with consumers who are passionate about innovations that are “made by nature, refined by science.” Rapid Nutrition’s first-class scientific team matches the experience of its management team to keep both the company and consumers on top of the latest industry trends and developments, while aligning with industry leaders worldwide to deliver effective supplements and solutions. Rapid Nutrition aims to be the supplier of choice globally by offering premium brands with the highest-quality ingredients to deliver maximum results.
For more information, please visit http://rnplc.com
Investor Relations Contact:
ir@rnplc.com
Disclaimer
This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and or otherwise that involve risks, uncertainties and assumptions that could cause Rapid Nutrition PLCs actual results and experience to differ materially from anticipated results and expectations expressed in these forward-looking statements. Rapid Nutrition PLC has in some cases identified forward-looking statements by using words such as "anticipates," "believes," "hopes," "estimates," "looks," "expects," "plans," "intends," "goal," "potential," "may," "suggest," and similar expressions. Rapid Nutrition PLC undertakes no obligation to release publicly the results of any revisions to any such forward-looking statements that may be made to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events, except as required by applicable law or regulation.
This media information does not constitute an offer to sell, or a solicitation of an offer to buy, any securities. This information does not constitute an offering prospectus within the meaning within the meaning of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 of June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71 or a listing prospectus within the meaning of the listing rules of the Euronext Exchange or OTC Markets. The media release is in accordance with International Reporting Standard: Rule 12g3-2(b) under the Securities Exchange Act ('Rule 12g3-2(b)') permits non-U.S. companies with securities listed primarily on a Qualified Foreign Exchange to make publicly available to U.S investors in English the same information that is made publicly available in their home countries as an alternative to SEC reporting Exchange Act Rule 12g3-2(b).
